Bell’s Healthcare

What Bell’s Healthcare does

Bell's Healthcare, legally Bell Sons & Co (Druggists) Limited, is a UK-based pharmaceutical manufacturer founded in 1848 as a pharmacy in Preston, Lancashire, and now operating from purpose-built GMP and MHRA approved facilities in Southport with a head office in Widnes and a 77,000 sq ft GDP-qualified warehouse in Knowsley. The company manufactures over-the-counter pharmaceuticals, prescription generics, and own-brand/private-label ranges across more than 150 product lines and almost 100 MHRA registered licences, running 9 flexible production lines capable of producing 20+ million units per year with a workforce of approximately 150 expert staff.

The business operates across three revenue streams: Bell's branded OTC products sold to UK wholesalers and international distributors, contract manufacturing of own-brand pharmaceutical ranges for leading UK supermarkets, and branded exports (Menthodex, Kilkof, Rexoguard) distributed through a network of importers across 65+ markets in Africa, Asia, Europe, the Middle East, Australia and North America. Pricing is quote-based under B2B contracts, and the go-to-market is sales-led direct engagement with channel partner distribution internationally.

Bell's Healthcare has been a wholly-owned subsidiary of Marksans Pharma Ltd, a publicly listed Indian pharmaceutical company, since 2008. The company is led by Managing Director Sathish Kumar K.J. Recent strategic activity includes the November 2021 opening of an NPD and small-scale manufacturing facility in Southport, the commissioning of a new Knowsley warehouse, and an October 2024 parent-company agreement to acquire a 47,500 sq m manufacturing site in India to expand into creams, ointments and other dosage forms.

Name

Bell’s Healthcare

Legal name

Bell Sons & Co (Druggists) Limited

Website

https://bells-healthcare.com

Company type

Private

Founded year

1848

Operating status

Operating

Headcount range

51–100 employees

Short description

Bell's Healthcare is a UK-based, MHRA and GMP approved pharmaceutical manufacturer producing over 20 million units annually across 150+ OTC, generic and own-label product lines, supplying UK wholesalers, leading UK supermarkets and international distributors across 65+ markets.

Ownership category

akta.pro rank

Product category

Over-the-counter pharmaceutical manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industry

Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD)

Keywords

• Over-the-counter pharmaceuticals
• Pharmaceutical contract manufacturing
• Own-label pharmaceutical supply
• Prescription generic medicines
• Pharmaceutical export distribution

Headquarters

HQ city

Widnes

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Own Brand Pharmaceutical Products: Manufacture and supply of Bell's branded over-the-counter pharmaceuticals to UK wholesalers and international distributors, including analgesics, allergy relief, cold remedies, and children's medicines
2. Contract Manufacturing / Own Label: Custom manufacturing of own-brand pharmaceutical ranges for leading UK supermarkets and overseas partners, with bespoke product development and reliable delivery
3. Generic Pharmaceuticals: Supply of generic medications including generics for hypertension, high cholesterol, type-2 diabetes, migraine, epilepsy, various cancers, analgesics, antidepressants and allergy relief
4. Export Products: International sales of British-made pharmaceutical products including Menthodex cold remedies, Kilkof and Rexoguard disinfectants, essential oils, and pharmacy professional ranges

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Core offering

Bell's Healthcare manufactures over-the-counter pharmaceutical products and prescription generics at its MHRA and GMP approved UK factory complex in Southport, producing more than 20 million units per year across nine flexible production lines. The company supplies over 150 product lines and almost 100 MHRA registered licences to UK wholesalers, leading UK supermarkets under own-brand/contract manufacturing arrangements, and international distributors across 65+ markets. It also provides dedicated R&D, in-house quality control, pharmacovigilance, and worldwide distribution from a 77,000 sq ft GDP qualified warehouse.

Product overview

Bell's Healthcare operates as a pharmaceutical manufacturer offering a portfolio of over 150 product lines and almost 100 MHRA registered licences. The portfolio includes OTC pharmaceuticals organized across UK branded products (analgesics, cough & cold, allergy relief, children's medicines, skin care, oils, pain relief, lip care, nasal care, ear care, women's health, stomach & constipation relief, and eye products) and international export products including the Menthodex, Kilkof, and Rexoguard branded ranges. Individual products include Ferrous Fumarate tablets, Magnesium Sulphate Paste, Paracetamol Elixir, Glycerin preparations, Gentian Violet, Children's Ibuprofen Oral Suspension, Ibuprofen Suspension, Folic Acid, Loperamide Diarrhoea Relief, Paracetamol Capsules, and Calamine Lotion. The company also provides prescription generics for hypertension, high cholesterol, type-2 diabetes, migraine, epilepsy, cancers, antidepressants, and allergy relief. Services include contract manufacturing with nine flexible production lines capable of producing 20 million units annually, R&D for new product development including oral suspension ranges, quality assurance with GMP/MHRA compliance and pharmacovigilance, and supply chain logistics with 77,000 sq ft warehousing. The company also supplies own-brand products to major UK supermarkets and exports to over 65 markets worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Menthodex: Established international brand for cold remedies
• Kilkof
• Rexoguard
• RelonChem

Products and services

• UK Branded OTC Pharmaceutical Portfolio More than 150 branded OTC pharmaceutical product lines manufactured in the UK and supplied to UK wholesalers and pharmacy/retail customers, including individual SKUs such as paracetamol elixir, children's ibuprofen oral suspension, ibuprofen suspension, ferrous fumarate tablets, folic acid liquid, loperamide diarrhoea relief capsules, paracetamol 500mg capsules, calamine lotion, magnesium sulphate paste, glycerin of borax, glycerin BP, gentian violet, and sodium bicarbonate.
• Own-Brand/Contract Manufacturing Service Bespoke UK contract manufacturing of own-brand/private label pharmaceutical ranges for supermarkets and overseas partners, supported by nine flexible production lines, an NPD and small-scale manufacturing facility for initial regulatory submission batches, in-house quality control, and worldwide dispatch from a GDP qualified warehouse.
• International Branded Pharmaceutical Export Ranges International branded pharmaceutical product ranges exported through a network of importers and distributors into 65+ markets across Africa, Asia, Europe, the Middle East and Australia, including the Menthodex cold remedy range, Kilkof and Rexoguard disinfectant brands, essential oils, baby and children's medicines, and pharmacy professional products.
• Prescription Generic Medicines Generic pharmaceutical products covering multiple therapeutic categories including hypertension, high cholesterol, type-2 diabetes, migraine, epilepsy, various cancers, analgesics, antidepressants and allergy relief, supplied to pharmacy and prescription distribution customers.
• Pharmaceutical R&D and New Product Development Service Research and development of new pharmaceutical formulations supported by a dedicated scientific team, quality and regulatory affairs professionals, a formal Quality Management System, and a dedicated NPD and small-scale manufacturing facility for initial regulatory submission batches and small-scale commercial production.

Quantifiable outcome

• Every batch micro-tested for quality assurance
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered minor and core.

• Warrington Rylands U11's Football ClubminorOthers · 1 January 2023Bell's Healthcare (along with RelonChem) has been a proud sponsor and supporter of Warrington Rylands U11's for several years. The team achieved an exceptional season in 2023/24, winning 8 trophies including National Champions.
• RelonChemminorGTM or Marketing PartnerCo-sponsor with Bell's Healthcare of Warrington Rylands U11's football team sponsorship initiative.
• UK Supermarkets (Own Brand Partners)coreChannel Partner/ Reseller/ DistributorBell's Healthcare is the pharmaceutical supplier of choice for a number of leading UK supermarkets for their own-brand medicines range. All partner own-brand products are manufactured to the same high standards as the rest of Bell's range.

Scale indicators9 records

Recent moves8 records

Expansion highlights4 records

Direct peers

• Ennogen Healthcare: UK-based pharmaceutical manufacturer focused on generics and specialty pharmaceuticals. Comparable to Bell's on UK manufacturing, MHRA licensing, generics portfolio, and supply to pharmacy wholesalers.
• Aspire Pharma: UK-based specialty generics and OTC pharmaceutical company supplying pharmacy and retail channels. Comparable to Bell's in product mix (prescription generics plus OTC), UK manufacturing base, and B2B/wholesale distribution model.
• Almus Pharmaceuticals: UK-based supplier of generic and OTC medicines focused on pharmacy and supermarket own-brand channels. Comparable to Bell's on the own-label contract manufacturing model and UK supermarket/pharmacy customer base.
• Thornton & Ross: UK-based OTC and generic pharmaceutical manufacturer owned by STADA, supplying own-brand and branded medicines to UK retailers and wholesalers. Highly comparable to Bell's on customer base (UK supermarket own-label), product portfolio (OTC, dermatology, generics), and contract manufacturing model.
• RelonChem: UK-based pharmaceutical company with overlapping generics and OTC portfolio and a co-marketing relationship with Bell's (joint sponsor of Warrington Rylands U11's). Comparable scale, UK base, generics/OTC focus, and export orientation to international markets.

Broad incumbents

• Perrigo Company: Global leader in store-brand OTC pharmaceuticals and generics, with significant UK/EU presence supplying retailer own-label programmes. Directly comparable business model to Bell's own-label contract manufacturing, but at much larger scale and with broader geographic footprint.
• STADA Arzneimittel AG: European generics and OTC pharmaceutical group that owns UK peer Thornton & Ross. Comparable in generics + OTC portfolio, European manufacturing footprint, and own-brand/contract manufacturing orientation; operates at much larger scale than Bell's.
• Haleon: Global OTC consumer healthcare company spun out of GSK in 2022, owning Panadol, Centrum, and other leading OTC brands. Competes with Bell's across the same UK OTC categories (analgesics, cold, allergy) but at vastly larger scale and brand investment.
• Reckitt Benckiser: Global consumer health major owning Nurofen, Gaviscon, Dettol, and Strepsils. Overlaps with Bell's on analgesics, cold/flu, and disinfectant ranges (Kilkof/Rexoguard), competing on UK and international shelves but with substantially larger marketing and R&D budgets.

Regional players

• Cipla (UK operations): Indian-headquartered global pharmaceutical group with UK generics and OTC presence. Comparable as an Indian pharma parent competing in UK generics/OTC space, and structurally similar to Bell's position within Marksans Pharma (Indian parent owning UK OTC subsidiary).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bell’s Healthcare